Oncology & Cancer

HPV testing could cut cervical cancers by a third

(Medical Xpress)—Testing women for the human papillomavirus (HPV) first, instead of using the traditional cervical screening test to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer ...

Oncology & Cancer

RNA assays up sensitivity of urothelial carcinoma detection

(HealthDay) -- Cxbladder, a derivative of the RNA assay uRNA, may be an effective alternative to cytology and nuclear matrix protein 22 (NMP22) assays for the detection of urothelial carcinoma, according to a study published ...

Oncology & Cancer

Study supports 'catch up' HPV test in older women

For women over the age of 65 who have never had a high-risk human papillomavirus (HPV) test, a "catch up" HPV screening intervention may improve cervical cancer prevention by detecting more cervical pre-cancer lesions as ...

Oncology & Cancer

Longer screening intervals possible with HPV-based tests

A new study from Karolinska Institutet in Sweden finds that testing for human papilloma virus (HPV) allows for longer time between screening tests when compared to cytology-based testing. The study is published in the scientific ...

Oncology & Cancer

FISH beneficial for diagnosing cholangiocarcinoma

(HealthDay)—Fluorescence in situ hybridization (FISH) is associated with increased sensitivity compared with brush cytology for diagnosing cholangiocarcinoma in indeterminate biliary strictures, according to a study published ...

page 2 from 3